YM BioSciences (TMI) Gets OK from U.S. FDA for Two Nimotuzumab Phase II's
Tweet Send to a Friend
YM BioSciences Inc. (AMEX: YMI), announced that the FDA has advised the Company that it may now enroll patients at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
